• 한국산업보건학회지
• /
• 제6권2호
• /
• pp.301-312
• /
• 1996

This study was performed to search a optimal analyzing method of cadmium in whole-blood. Cadmium was determined by graphite furnace atomic absorption spectrometry(GFAAS). We investigated the effect of ashing temperature on the absorbance of cadmium in a simple dilution(ten-fold) method with triton X-100 and matrix modifier methods treated with $NH_4H_2PO_4$(1 and 3%) and $Pd(NO_3)_2$(0.00l and 0.005%) as matrix modifier. We also compared the reported reference values of standard blood with values resulted from optimal analyzing conditions of this study. In case of a simple dilution method, when ashing temperature was set at $450^{\circ}C$, the absorbance of sample and background were $0.334{\pm}0.012$ and $1.382{\pm}0.245$, respectively. Background level was higher than the value(0.8) that can be corrected by $D_2$ background correction method. As ashing temperature was rised to $500^{\circ}C$, the absorbance of sample and background were $0.178{\pm}0.008$ and $0.711{\pm}0.223$ respectively. The higher ashing temperature($450^{\circ}C-650^{\circ}C$) was, the lower the absorbance of sample was. In case of a matrix modifier method with $NH_4H_2PO_4$(1 and 3%), when ashing temperature was rised from $500^{\circ}C$ to $650^{\circ}C$, the absorbance of sample slightly changed. The absorbances of sample at $600^{\circ}C$ were $0.230{\pm}0.017$ and $0.137{\pm}0.012$, respectively. These values were larger than that of simple dilution method. But the absorbance of background was higher than the level that can be corrected by $D_2$ method. In case of a matrix modifier method with $Pd(NO_3)_2$(0.001 and 0.005%), the absorbance of sample and background were higher than those of other methods and were stable and reproducible. When ashing temperature was over $550^{\circ}C$, the absorbance of sample was significantly decreased. In case of 0.005% $Pd(NO_3)_2$ carbon residue remained in graphite tube affected the absorbance of sample and background. From these results, We propose that in case of a simple dilution(ten-fold) method with triton X-100 ashing temperature must be maintained below $400^{\circ}C$. In order to diminish the absorbance of background, the alternative method is attenuation of injection volume or multiplication of dilution ratio. We recommend $Pd(NO_3)_2$ than $NH_4H_2PO_4$ as a matrix modifier. In case of a matrix modifier method with $Pd(NO_3)_2$ ashing temperature might be maintained below $550^{\circ}C$.

• 분석과학
• /
• 제8권4호
• /
• pp.435-442
• /
• 1995

A matrix modification was studied for the determination of trace bismuth in water samples by graphite furnace atomic absorption spectrophotometry. The type and quantity of modifiers as well as the use of auxiliary modifiers were investigated to realize the efficient modification. Palladium was chosen as a single modifier. By the addition of palladium($5{\mu}g/mL$) to 100 ng/mL bismuth solution, the temperatures could be raised from $500^{\circ}C$ to $1,300^{\circ}C$ for the charring and from $2,000^{\circ}C$ to $2,200^{\circ}C$ for the atomization as well as the sensitivity and reproducibility were improved. The absorbance of bismuth was maximum and not changed in the range of Pd $3-25{\mu}g/mL$. And several materials were examined as an auxiliary modifier. The mixed solution of $1{\mu}g/mL$ palladium and $200{\mu}g/mL$ nickel have raised the temperatures as with $5{\mu}g/mL$ palladium only. The maximum absorbance of bismuth was shown in the nickel concentration range of $100-300{\mu}g/mL$ in $1{\mu}g/mL$ palladium modified system. With such optimum conditions, the trace amount of bismuth in several water samples could be determined by a calibration curve method, and good recoveries were also obtained.

• Journal of Pharmaceutical Investigation
• /
• 제38권3호
• /
• pp.191-197
• /
• 2008

The purpose of the present study was to examine the pharmacokinetics and lymphatic delivery of the oligopeptide, a model peptide of X antigen epitope peptides, after the intramuscular administration of the peptide-bearing liposomes in rats. $^{14}C$-labelled peptide was used as a tracer to analyze the peptide levels in plasma, bile, urine, tissue homogenates, and lymph nodes (superior cervical nodes, brachial nodes and superior mesenteric nodes). Model peptide rapidly disappeared from the plasma by 30 min (${\alpha}$ phase) after i.v. administration, which was followed by the late disappearance. The apparent plasma half-lives ($t_{1/2({\alpha}),app}$) of the peptide at the ${\alpha}$ phase when administered at a dose of 0.2-1.0 mg/kg were about 5 min. The maximum plasma concentration ($C_{max}$) was $1.52\;{\mu}g/mL$, after the i.m. administration of the peptide at a dose of 1.0 mg/kg. The bioavailability, which was calculated from the time zero to last quantitative time, of the i.m. administered peptide was over 60%. Of the various tissues tested, the peptide was mainly distributed in the kidney after the i.m. administration. The peptide levels in the kidney 3 hr after the i.m. administration were higher than those of maximum plasma concentration ($C_{max}$). The cumulative amounts of the peptide found in the urine 72 hr after the administration of 1.0 mg/kg were 2-folder higher than those in the bile, suggesting that the peptide is mostly excreted in the urine. Moreover, the concentrations of the peptide in the lymph nodes were as high as that of the plasma and the tissues. In conclusion, the peptide concentration in the lymph nodes was maintained by 24 hr after the i.m. administration of the peptide-bearing liposomes.

• Archives of Pharmacal Research
• /
• 제28권4호
• /
• pp.476-482
• /
• 2005

We investigated the pharmacokinetics of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, after intravenous (i.v.) bolus administration at a multiple dose every 24 h for 5 days in rats. To analyze ID-6105 levels in biological samples, we used an HPLC-based method which was validated in a pharmacokinetic study by suitable criteria. The concentrations of ID-6105 after the multiple administration for 5 days were not significantly different from the results after the single administration. The $t_{1/2\alpha}, t_{l/2\beta}, V_{dss}, and CL_{t}$ after the multiple administration were not significantly different from the values after the single administration. Moreover, the concentrations of ID-6105 1 min at day 1-5 after i.v. bolus multiple administration did not show the significant difference. Of the various tissues, ID-6105 mainly distributed to the kidney, lung, spleen, adrenal gland, and liver after i.v. bolus multiple administration. ID-6105 concentrations in the kidney or lung 2 h after i.v. bolus administration were comparable to the plasma concentration shortly after i.v. bolus administration. However, the ID-6105 concentrations in various tissues 48 h after i.v. bolus administration decreased to low levels. ID-6105 was excreted largely in the bile after i.v. bolus multiple administration at the dose of 3 mg/kg. The amounts of ID-6105 found in the bile by 12 h or in the urine by 48 h after the administration were calculated to be $14.1\% or 4.55\%$ of the initial dose, respectively, indicating that ID-6105 is mostly excreted in the bile. In conclusion, ID-6105 was rapidly cleared from the blood and transferred to tissues, suggesting that ID-6105 might not be accumulated in the blood following i.v. bolus multiple dosages of 3 mg/kg every 24 h for 5 days. By 48 h after i.v. bolus administration, ID-6105 concentrations in various tissues had decreased to very low levels. The majority of ID-6105 appears to be excreted in the bile.

• 한국작물학회지
• /
• 제42권1호
• /
• pp.14-21
• /
• 1997

본 시험은 직파재배 유형에 따른 생육 및 수량을 밝히고자 동벼와 농안벼를 공시하여 수행하였던 바 그 결과를 요약하면 다음과 같다. 1. 직파재배 유형간 입수수는 건답평면세조파에서 가장 많았고 무논골뿌림재배에서 적었다. 2. 초기의 경수 증가 속도는 어린모 기계이앙재배가 빨랐으며 유교경비율은 직파재배가 이앙재배보다 낮았다. 3. 출수일수는 직파재배가 어린모 기계이앙재배보다 동진벼는 2∼13일, 농안벼는 10∼18일 길었다. 4. 뿌리의 표층 분포 비율은 담수표면산파>담수표면조파>무논골뿌림>건답평면세 조파>어린모 기계이앙재배 순으로 높았다. 5. 제4절간의 굵기는 재배유형간에 차이가 없었으며 제4절간의 간벽두께는 어린모 기계 이앙재배가 직파재배보다 두꺼웠고 줄기 매몰깊이는 어린모 기계이앙>건답평면세 조파>무논골뿌림>담수표면 조파>담수표면산파 순으로 깊었다. 6. 중심고는 직파재배가 어린모 기계이앙재배보다 높았고 모멘트는 어린모 기계이앙재배가 낮았으며 도복지수는 어린모 기계이앙재배가 가장 낮았고 무논골뿌림, 건답평면세 조파, 담수표면조파, 담수표면산파 순으로 낮았다. 7. 도복은 농안벼에서는 발생하지 않았거나 매우 경미하였으나 동진벼는 담수표면직파>담수표면조파>무논골뿌림>건답직파=어린모 기계이앙의 순으로 도복발생이 심하였다. 8. 수량 구성요소와 수량성은 품종간에는 유의적인 차이가 인정되었으나, 어린모 기계이앙 재배와 직파재배, 그리고 직파재배와 유형간에는 유의적인 차이가 없었다.

• 센서학회지
• /
• 제3권3호
• /
• pp.9-15
• /
• 1994

비표면적이 큰 ${\gamma}-Al_{2}O_{3}$와 귀금속 촉매를 이용하여 접촉연소식 가스감지소자를 제조하였다. DT/TGA와 XRD 실험을 통해 ${\gamma}-Al_{2}O_{3}$ 제조의 최적 조건을 구하였으며, 제조된 ${\gamma}-Al_{2}O_{3}$는 $215.5m^{2}/g$의 큰 비표면적을 나타내었다. Pt 코일을 발열체 및 온도감지소자, 미세 ${\gamma}-Al_{2}O_{3}$ 분말을 담체 모물질, Pd 및 Pt 귀금속을 촉매제로 이용하여 가스센서를 제조하고 가연성 가스에 대한 감도특성을 조사하였다. 실험결과들로부터 본 연구에서 제조된 센서는 1000ppm의 LPG 및 LNG에 대해 각각 20mV와 6.5mV로 놀은 감도 특성을 나타내었다.

• 한국식품과학회지
• /
• 제41권1호
• /
• pp.77-81
• /
• 2009

Streptozotocin-유도 당뇨병 모델을 이용하여 흑삼의 혈당강하작용에 대한 효과를 연구하고 증포과정에 따른 ginsenoside의 조성 변화를 분석하였다. 증포별 ginsenoside의 정량분석 결과, 증포 횟수가 증가할수록 조사포닌의 총량과 대부분의 ginsenoside는 줄어든 반면 ginsenoside-$Rg_3$ 함량 및 PD/PT 비율은 증가하는 경향을 보였는데, 이러한 조성은 다른 인삼제품과는 차별성 있는 특징이다. 또한, streptozotocin-당뇨병 유발쥐를 이용한 모델실험에서 흑삼추출물의 투여는 고혈당 준위(300 mg/dL이상)를 정상 수준(102 mg/dL)으로 감소시켰으며, 혈당 수준의 감소는 glycolysis나 HMT shunt 및 지방산 합성에 관여하는 glucokinase, glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, acetyl CoA carboxylase 등의 효소의 활성증대에 기인하는 것으로 판단되었다. 이러한 결과는 흑삼추출물의 유의적인 혈당강하 효과를 입증하며 이에 따라 신약이나 식이보조제의 항당뇨물질로서의 이용가능성을 시사한다.

• 멤브레인
• /
• 제22권1호
• /
• pp.1-7
• /
• 2012

니오븀 금속을 기반으로 하는 $Nb_{56}Ti_{23}Ni_{21}$ 합금 분리막의 수소 투과 특성 및 화학적 안정성에 관한 연구를 수행하였다. 이를 위하여 직경 10 mm, 두께 0.5 mm의 $Nb_{56}Ti_{23}Ni_{21}$ 합금 분리막을 제작하였으며, 2가지 조성($H_2$ 100%, $H_2$ 60% + $CO_2$ 40%)의 공급가스를 $450^{\circ}C$의 온도에서 투과시킬 때 압력에 따른 수소 투과 특성에 관한 실험을 진행하였다. 본 실험에서의 최대 수소 투과량은 순수한 수소를 투과시킬 경우 절대압력 3 bar에서 $5.58mL/min/cm^2$로 나타났다. 또한 공급가스 조성에 따른 각각의 경우 모두 Sievert's law에 잘 부합하였으며, 이산화탄소와의 혼합가스 사용시, 투과량은 수소 분압 감소에 비례하여 감소하였다. 투과 실험 후 XRD 분석을 통하여 $Nb_{56}Ti_{23}Ni_{21}$ 합금 분리막의 이산화탄소에 대한 화학적 안정성에 대한 실험을 수행하였다.

• The Journal of Korean Physical Therapy
• /
• 제26권2호
• /
• pp.48-55
• /
• 2014

Purpose: The purpose of this study was to examine correlations among UPDRS, respiratory function, and senior fitness and to investigate the effects of restrictive respiratory function on these factors in Parkinson's disease patients. Methods: Subjects (n=25, Hoehn & Yahr (H&Y) stage: 2-3, $69.3{\pm}5.9$ yrs) from D Hospital Parkinson's Disease Center at Busan metropolitan area in the Republic of Korea volunteered for this study. They performed the pulmonary function test, UPDRS, and the senior fitness test. SPSS 18.0 was used for analysis of data, and the collected data were analyzed using Pearson's correlation coefficient (n=25). In addition, Independent t-test was used for determination of differences between two groups (between the normal pulmonary function group (n=10) and the restrictive pulmonary function group (n=10)). Results: Forced vital capacity (FVC (L)) showed significant negative correlation (r=-0.44, p<0.05) with H&Y stage in Parkinson's disease patients, and chair stand showed significant negative correlations (r=0.41, 0.43, 0.42, p<0.05) with FVC (L), FVC (%), and FEV1 (L). FVC (%) showed significant positive correlations (r=0.44, r=0.44, p<0.05) with right and left back scratch. In addition, the restrictive respiratory function group showed significantly lower FVC (%) (p<0.01) and was significantly slower (p<0.05) in the 8-foot up-and-go test than the normal respiratory function group. Conclusion: In conclusion, these results suggest that restrictive respiratory function in PD was related to H&Y stage. In addition, agility of PD patients was lower in the restrictive respiratory function group than in the normal function group.

• 한국동물위생학회지
• /
• 제45권2호
• /
• pp.139-143
• /
• 2022

A 10-year-old, spayed female miniature schnauzer was referred to the Veterinary Medical Teaching Hospital of Chungnam National University due to evaluation of sudden polyuria (PU) and, polydipsia (PD) (540 mL/kg/day) with severe anemia and weight loss. Blood examination results were normal except for severe anemia (hematocrit, [HCT]: 11.8%). Urinalysis revealed a urine specific gravity (USG) of 1.003, whereas urine sediment was not specific. Urine osmolality was 90 mOsm (reference range: 800~2500 mOsm), and plasma osmolality was 303 mOsm. No specific lesions were found using diagnostic imaging including radiography, ultrasonography and magnetic resonance imaging (MRI). The serum cortisol level was normal in cosyntropin stimulation test. Plasma arginine vasopressin (AVP) concentration was <0.4 pg/mL (reference range: 3.49~5.45 pg/mL). Blood transfusion was initiated in addition to an oral prescription of desmopressin acetate (DDAVP, 0.1 mg/head) thrice a day for one week. The patient was rechecked for clinical signs, urine osmolality, and USG; the clinical signs of PU/PD were resolved, urine osmolality increased to 1106 mOsm, and, USG increased to 1.021. Considering the improved clinical signs, and increased urine osmolality, and USG after DDAVP treatment, the dog was diagnosed with central diabetes insipidus. USG and urine osmolality increased to >1.030 and 2200 mOsm, respectively. Anemia also gradually improved and HCT increased to >37%. DDAVP was tapered to 0.1 mg/head twice a day and all clinical signs in the patient have completely resolved.